{"ticker": {"uuid": "ea80ca6e-e2eb-4072-9a05-83956c069224", "symbol": "MDNA", "name": "Medicenna Therapeutics Corp.", "exchange": "TOR", "country": "CA", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "What's Going On With Medicenna Therapeutics Corp Stock Wednesday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPejhJRkdGaVZmVTltQXNFTVNmMXNmNWVubndhb1h0NXpBcjRNUnhMUEFSRE1qUEJuS21kRFdkMFNHMThtUG52X0JpWHFOSnBtbjVRc21JQzZZYjJBVklvUjlBVXdCYjFMUlRRQ3BneUNWWnhubXBwVFZuNm13QlhFN2t2aWE0UGlUYjhkNkJPU2JQYTNJdXhSSi1ZbVdYd1VIenRydg?oc=5", "source_name": "Wealth Awesome", "published_at": "2026-07-16T03:31:50+00:00", "published_display": "16 Jul 2026 03:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicenna Therapeutics outlines its cytokine platform strategy as investors watch MDNA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPREFER1pVQk1uaDU5RXh3UlYxMGVGSGZHZ21qdUFTNlV2UVoxdFBZVkhhZDFCSUs3MnRRczZoOFoyQk9kTW5vTGJQajJsOGhRRU9sZXpaUjdyNWo5LVE5VEdkTzlVbW9vUWpkc2E5TGs2ZHBCTDhLWDJQQzdPbjM4cE9LU182RVFGdHdhSzRYNGktU3lOTkUwMGI5NG5XOGJhNC1pajYwR1hYdEpWbVhMMHp1ZGRPMDBEUFY3cmpYUWFqQQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-07T14:46:54+00:00", "published_display": "07 Jul 2026 14:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDNAF SEC Filings - Medicenna Therapeutics Corp 10-K, 10-Q, 8-K Forms", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE5Ob1A0MFdJVlpXNUlBakhGMDZvYlh3R3Zxb1N4M3pYSHBFeW42QlJmSTZic1JtcklheEhTTWo0Q0VfNkRkR3k2Q083cUx0MUdfVF90cHlyZnU?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicenna Therapeutics explores its cancer pipeline as investors watch clinical progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOSUY0ZHFvSFN3WHN0bU5ZcHV0bWgzRjNodTQzYno2MTBZandxRnRjUndWb3R1QkY1bjlqdGRQY0xVS0tYVmo4TnhjaGt5VFhacXd5LUtocmlJOEg3d2tSTjlTeElZSTNwNm5UdWR6Vko3WDNmWWdxdUxjb2l5aEhrTEJBSXFXd2V1Q2w5el9UbGdfWWlNeVpHcllQQjFud2gyS21zYUhuRUw3cmhqZUZpbVljUHppcnJGcGxGWXMtVnBvNXR1OGZaeQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-03T16:15:03+00:00", "published_display": "03 Jul 2026 16:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TSX Insights Medicenna Therapeutics And 2 Other Promising Penny Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOZW8wNnkwUlNseHJNTkFXLWNZOXlncGhCRy1rUC1YNm05VVNEZUNlV3N1U3dVeU41N1o1VGwwS2MwQ25aeTNjeVR3cmYxS25za0NyUVZaNHhrQl9xNktuV1dfZnRITlh2UDRJdi0wSjdTd2N5d3JHOTEtR3RkdGREU1JkN0EtVzNpSDkw?oc=5", "source_name": "Market source", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're Watching Medicenna Therapeutics' (TSE:MDNA) Cash Burn Situation", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOWGFuMURpSkVnYlJpQ0g1ZVAwWVlZNEZuNkVfVF9ZTUE2aE9lZHp4ZTFyQldXajU1SVVWMnVRWDV2VzR3eXZtYklvQ3pPaEVWeW1iZ0FhbHgxZTUtZ0NDSnA4VzJsdHowSjRNXzYzeVdMQTZQQWtJME01X2ZlazJETjJNQ0ZxZw?oc=5", "source_name": "Market source", "published_at": "2026-01-26T08:00:00+00:00", "published_display": "26 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicenna Therapeutics Reports Second Quarter Fiscal 2026 Financial Results and Provides a Corporate Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQRFpScWxxdzZMM3FOTEgzRDFWb0k1MDJQVW1XOEtxWFp6T3c4TDZ0cE5UalZJamtaR18tNkZzZmFnTWE5bEdacUl5VXhMVFZqSG9Ba0IydVJIUDhDazRSUVNyNWFaQlBrMzJJeXhwUWFlNU9abEUzMS1FRHF6d2Y3dHA1SjQ3Y2stSklNb002NWlreXdnSVZmcVg4YVlCSmFSYmY5ZHRPSS1ZTjlGVzBvMzVkX2tnR0JQMHVMMVU1WnBUemsySUJyWGZBWlBBcE0?oc=5", "source_name": "Investing News Network", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicenna keeps Speculative Buy rating with Research Capital", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQVXdRSjFNbGRaUERhcEp2ZWVuM0JKb1h6djQ2TFJZc2xSVXBDekg5RjJEYWxsaGlUM2pudFVSVklVcjk4Q2xqN0hTYkhsSEFSZ0xjb3pQWkFIN2NZVGpINzZjQ05uY2VXbmVpMC1TUzhDZnpmd2ZpamxWWnh0czhTZGYtS0Q4cUFGclZ0TVdEVEdxZV91MzBsdDdCS2lSNDh0UVdSTnc0Y9IBrAFBVV95cUxOQzJpVVFfbTJOejM4M0pjczNNZWEweVlySGhsdWFMSzJOLV90X3FDM081Q281QU5QZ3lRYW9zbUlnSE5CVThodVdYMDFTQkRPeFJjU04yTm5oWTF2eEoweDZhbm1scFNoYXBMalFuZzNaQU9wVFpUeUV2UlFxTlFnOWkzNGwtSmhUV1p5Z3pCMnlIZE9wYURvY1RZcEtjMnRxd3JpSGYxdE8yMWYx?oc=5", "source_name": "Cantech Letter", "published_at": "2022-11-07T08:00:00+00:00", "published_display": "07 Nov 2022 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicenna Therapeutics Stock Price Forecast. Should You Buy MDNA.TO?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTEFVX3lxTE1naGFHQVBwMFpCQTNMWVZoamNsMDJ1WllHZWVYR3ZURy1ORDNSelhQVkJoY0lPNTJSXzFLMHlRSEc1WEZfWjN5RU9zeGU?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-04T23:25:14+00:00", "published_display": "04 Dec 2020 23:25", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "What's Going On With Medicenna Therapeutics Corp Stock Wednesday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPejhJRkdGaVZmVTltQXNFTVNmMXNmNWVubndhb1h0NXpBcjRNUnhMUEFSRE1qUEJuS21kRFdkMFNHMThtUG52X0JpWHFOSnBtbjVRc21JQzZZYjJBVklvUjlBVXdCYjFMUlRRQ3BneUNWWnhubXBwVFZuNm13QlhFN2t2aWE0UGlUYjhkNkJPU2JQYTNJdXhSSi1ZbVdYd1VIenRydg?oc=5", "source_name": "Wealth Awesome", "published_at": "2026-07-16T03:31:50+00:00", "published_display": "16 Jul 2026 03:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicenna Therapeutics outlines its cytokine platform strategy as investors watch MDNA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPREFER1pVQk1uaDU5RXh3UlYxMGVGSGZHZ21qdUFTNlV2UVoxdFBZVkhhZDFCSUs3MnRRczZoOFoyQk9kTW5vTGJQajJsOGhRRU9sZXpaUjdyNWo5LVE5VEdkTzlVbW9vUWpkc2E5TGs2ZHBCTDhLWDJQQzdPbjM4cE9LU182RVFGdHdhSzRYNGktU3lOTkUwMGI5NG5XOGJhNC1pajYwR1hYdEpWbVhMMHp1ZGRPMDBEUFY3cmpYUWFqQQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-07T14:46:54+00:00", "published_display": "07 Jul 2026 14:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDNAF SEC Filings - Medicenna Therapeutics Corp 10-K, 10-Q, 8-K Forms", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE5Ob1A0MFdJVlpXNUlBakhGMDZvYlh3R3Zxb1N4M3pYSHBFeW42QlJmSTZic1JtcklheEhTTWo0Q0VfNkRkR3k2Q083cUx0MUdfVF90cHlyZnU?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicenna Therapeutics explores its cancer pipeline as investors watch clinical progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOSUY0ZHFvSFN3WHN0bU5ZcHV0bWgzRjNodTQzYno2MTBZandxRnRjUndWb3R1QkY1bjlqdGRQY0xVS0tYVmo4TnhjaGt5VFhacXd5LUtocmlJOEg3d2tSTjlTeElZSTNwNm5UdWR6Vko3WDNmWWdxdUxjb2l5aEhrTEJBSXFXd2V1Q2w5el9UbGdfWWlNeVpHcllQQjFud2gyS21zYUhuRUw3cmhqZUZpbVljUHppcnJGcGxGWXMtVnBvNXR1OGZaeQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-03T16:15:03+00:00", "published_display": "03 Jul 2026 16:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TSX Insights Medicenna Therapeutics And 2 Other Promising Penny Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOZW8wNnkwUlNseHJNTkFXLWNZOXlncGhCRy1rUC1YNm05VVNEZUNlV3N1U3dVeU41N1o1VGwwS2MwQ25aeTNjeVR3cmYxS25za0NyUVZaNHhrQl9xNktuV1dfZnRITlh2UDRJdi0wSjdTd2N5d3JHOTEtR3RkdGREU1JkN0EtVzNpSDkw?oc=5", "source_name": "Market source", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're Watching Medicenna Therapeutics' (TSE:MDNA) Cash Burn Situation", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOWGFuMURpSkVnYlJpQ0g1ZVAwWVlZNEZuNkVfVF9ZTUE2aE9lZHp4ZTFyQldXajU1SVVWMnVRWDV2VzR3eXZtYklvQ3pPaEVWeW1iZ0FhbHgxZTUtZ0NDSnA4VzJsdHowSjRNXzYzeVdMQTZQQWtJME01X2ZlazJETjJNQ0ZxZw?oc=5", "source_name": "Market source", "published_at": "2026-01-26T08:00:00+00:00", "published_display": "26 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicenna Therapeutics Reports Second Quarter Fiscal 2026 Financial Results and Provides a Corporate Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQRFpScWxxdzZMM3FOTEgzRDFWb0k1MDJQVW1XOEtxWFp6T3c4TDZ0cE5UalZJamtaR18tNkZzZmFnTWE5bEdacUl5VXhMVFZqSG9Ba0IydVJIUDhDazRSUVNyNWFaQlBrMzJJeXhwUWFlNU9abEUzMS1FRHF6d2Y3dHA1SjQ3Y2stSklNb002NWlreXdnSVZmcVg4YVlCSmFSYmY5ZHRPSS1ZTjlGVzBvMzVkX2tnR0JQMHVMMVU1WnBUemsySUJyWGZBWlBBcE0?oc=5", "source_name": "Investing News Network", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicenna keeps Speculative Buy rating with Research Capital", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQVXdRSjFNbGRaUERhcEp2ZWVuM0JKb1h6djQ2TFJZc2xSVXBDekg5RjJEYWxsaGlUM2pudFVSVklVcjk4Q2xqN0hTYkhsSEFSZ0xjb3pQWkFIN2NZVGpINzZjQ05uY2VXbmVpMC1TUzhDZnpmd2ZpamxWWnh0czhTZGYtS0Q4cUFGclZ0TVdEVEdxZV91MzBsdDdCS2lSNDh0UVdSTnc0Y9IBrAFBVV95cUxOQzJpVVFfbTJOejM4M0pjczNNZWEweVlySGhsdWFMSzJOLV90X3FDM081Q281QU5QZ3lRYW9zbUlnSE5CVThodVdYMDFTQkRPeFJjU04yTm5oWTF2eEoweDZhbm1scFNoYXBMalFuZzNaQU9wVFpUeUV2UlFxTlFnOWkzNGwtSmhUV1p5Z3pCMnlIZE9wYURvY1RZcEtjMnRxd3JpSGYxdE8yMWYx?oc=5", "source_name": "Cantech Letter", "published_at": "2022-11-07T08:00:00+00:00", "published_display": "07 Nov 2022 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicenna Therapeutics Stock Price Forecast. Should You Buy MDNA.TO?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTEFVX3lxTE1naGFHQVBwMFpCQTNMWVZoamNsMDJ1WllHZWVYR3ZURy1ORDNSelhQVkJoY0lPNTJSXzFLMHlRSEc1WEZfWjN5RU9zeGU?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-04T23:25:14+00:00", "published_display": "04 Dec 2020 23:25", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 9, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 7, "score": 53, "total": 9, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.37, "latest_week": "2026-07-10", "one_week_move": -6.3, "four_week_move": -11.9, "twelve_week_move": -39.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.00673, "market_dynamics_buy_signal": false, "relative_strength": -63.299738, "fair_value_gap": -68.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 35.7964, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-6.3% over one week, -11.9% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "ad-hoc-news.de", "count": 2}, {"label": "Market source", "count": 2}, {"label": "Wealth Awesome", "count": 1}, {"label": "Stock Titan", "count": 1}, {"label": "Investing News Network", "count": 1}, {"label": "Cantech Letter", "count": 1}, {"label": "StockInvest.us", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 9}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}, {"label": "Balance sheet", "count": 1}, {"label": "Earnings", "count": 1}, {"label": "Analyst action", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "9", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-6.3% over one week, -11.9% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "What's Going On With Medicenna Therapeutics Corp Stock Wednesday?"}], "updated_at": "2026-07-18T05:22:38.919677+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}